Global Bone grafting Market Trends, Drivers, Strategies, Segmentation Application, Technology and Forecast 2027

Bone grafting Market is a surgical procedure carried out fix facture bones and bone injury. The procedure involves transplantation of bone tissues to augment and regenerate bones that are lost due to diseases or some injuries.

Considering all these factors, the global market of bone graft substitute is expected to reach $ 5,031.0 million by the end of 2027, this market is projected to grow at a CAGR of ~ 6.52 % during the forecast period 2017-2027.

Key Findings:

Americas accounted for the largest market share in 2016, and is projected to grow at a CAGR of 6.1% during the forecast period
Europe was the second-largest market in 2016 and is projected to grow at a CAGR of 6.76%
Asia Pacific is projected to show the fastest growth at the CAGR of 6.85% during the forecast period 2017-2027
The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructive orthopedic treatments. The adoption of bone graft substitutes in the oral healthcare sector is another factor responsible for catalyzing the growth of the bone graft substitutes market through the assessment period.

The bone graft substitutes market is poised to remain highly lucrative in the foreseeable future. However, risks associated with disease transmission in allografts and xenograft as well as graft rejection, improper fixation, etc. are prognosticated to restrict the market expansion over the forecast period.

Avail sample copy for this Report at: https://www.marketresearchfuture.com/sample_request/1195

Sone of the key players profiled in the report includes ACE Surgical Supply Company, Inc., Dentium Co., Ltd., BioHorizons IPH, Inc., Dentsply Sirona, Medtronic plc, Stryker Corporation, Zimmer Biomet, and Institut Straumann AG.

Market Segmentation:

By type, the global bone graft substitutes market is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.

By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.

Industry Developments:

In August 2018, BoneSupport, a Scandinavian orthobiologics company, won Health Canada approval for Cerament G bone graft substitute.

In September 2018, Baxter International Inc., an American healthcare company, received FDA clearance for its Actifuse Flow bone graft substitute. It shall be used in orthopedic surgical procedures.

The global bone graft substitutes market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the largest share of the global market in 2016. It is expected to retain a significant share of the market by the end of 2027 striking a CAGR of 6.1%. The growth is attributable to the technological advancements in health care, the presence of key players, etc.

Access Report @ https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195

The bone graft substitutes market is poised to remain highly lucrative in the foreseeable future. However, risks associated with disease transmission in allografts and xenograft as well as graft rejection, improper fixation, etc. are prognosticated to restrict the market expansion over the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.